<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01775007</url>
  </required_header>
  <id_info>
    <org_study_id>2008-P-002176/10</org_study_id>
    <nct_id>NCT01775007</nct_id>
  </id_info>
  <brief_title>A Pilot Study to Test the Safety and Feasibility of a Brillouin Ocular Analyzer</brief_title>
  <acronym>Brillouin I</acronym>
  <official_title>A Pilot Study to Test the Safety and Feasibility of a Brillouin Ocular Analyzer</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Massachusetts General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Massachusetts General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A Brillouin ocular analyzer uses a low-power near infrared laser light to probe the
      viscoelastic properties of the cornea and crystalline lens in the eye. The study hypothesis
      is that the instrument can measure the Brillouin light scattering spectra from the eye safely
      and effectively from human subjects.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 2011</start_date>
  <completion_date type="Actual">September 2017</completion_date>
  <primary_completion_date type="Actual">September 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of patients with adverse events</measure>
    <time_frame>6 months</time_frame>
    <description>Complete standard eye exam including medical and ocular history with manifest refraction, Amsler grid evaluation (macular test), color vision (Ishihara color plates), Scotopic pupil measurement (Colvard pupillometer), Slit lamp biomicroscopy of anterior segment, intraocular pressure measurement, dilated fundoscopic exam (2.5% phenylephrine and 0.5% tropicamide), and corneal topography (Pentacam).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Sensitivity and accuracy of Brillouin modulus measurement.</measure>
    <time_frame>at time of imaging session</time_frame>
    <description>It will be tested if, with the parameters designed for in vivo operation, the Brillouin ocular analyzer is sensitive enough to characterize the elasticity of cornea and crystalline lens as well as its spatial distribution within the ocular tissue.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">31</enrollment>
  <condition>Measurement of the Elasticity of the Anterior Eye Segment</condition>
  <arm_group>
    <arm_group_label>Normal Healthy Subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Brillouin Ocular Analyser</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Brillouin Ocular Analyser</intervention_name>
    <description>Measurement of the local viscoelastic properties (Brillouin Shift) of the Anterior Eye Segment.</description>
    <arm_group_label>Normal Healthy Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy volunteers aged 20-60

          -  No refractional abnormalities

          -  Clear enough cornea and media to permit imaging

        Exclusion Criteria:

          -  Occludable narrow angles (without a patent peripheral iridotomy)

          -  Other ocular or systemic pathology, which precludes safe eye dilation

          -  LASIK eye surgery

          -  Allergies to the dilation medication

          -  Only one healthy eye

          -  Pregnant women or expected pregnancy within the timeframe of the study

          -  Do not or cannot understand the instructions for the imaging

          -  Restricted mobility
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seok-Hyun Yun, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Massachusetts General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Massachusetts Eye and Ear Infirmary</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Massachusetts General Hospital</name>
      <address>
        <city>Boston</city>
        <state>Massachusetts</state>
        <zip>02114</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Scarcelli G, Yun SH. In vivo Brillouin optical microscopy of the human eye. Opt Express. 2012 Apr 9;20(8):9197-202. doi: 10.1364/OE.20.009197.</citation>
    <PMID>22513631</PMID>
  </results_reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>January 22, 2013</study_first_submitted>
  <study_first_submitted_qc>January 22, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 24, 2013</study_first_posted>
  <last_update_submitted>March 6, 2019</last_update_submitted>
  <last_update_submitted_qc>March 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Massachusetts General Hospital</investigator_affiliation>
    <investigator_full_name>Seok Hyun Yun</investigator_full_name>
    <investigator_title>Associate Physicist / Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Lens</keyword>
  <keyword>Cornea</keyword>
  <keyword>Presbyopia</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

